This study demonstrated the effectiveness and safety of bedinvetmab administered monthly for up to 9 months at 0.5-1.0 mg kg⁻¹ for alleviation of pain associated with canine osteoarthritis.
No takes yet. Share an insight, caveat, or question.
Corral et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: